Senior insider sale
Chief Executive Officer at LEGEND BIOTECH CORP — senior position signals high conviction
$2.11M
64.56K shares
What this filing means
HUANG YING plans to sell 64.56K shares of LEGEND BIOTECH CORP valued at approximately $2.11M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/26/2024ACC: 0001959173-24-008832
DirectorOfficer· Chief Executive Officer
Since Mar 2026
64.56K
Shares to sell
$2.11M
Approx. market value
63.06K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
12/20/2024
63.06KTotal acquired63.06K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/20/2024 | Restricted Stock Vesting Compensation | 63.06K | — |
| Total | 63.06K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.50K
Market value
$66.3K
9/25/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
63.06K
Market value
$2.05M
12/24/2024
Total
Units
64.56K
Value
$2.11M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/25/2024 | 1.50K | $66.3K | — | Completed |
| Planned — Approximate Date | ||||
12/24/2024 | 63.06K | $2.05M | NASDAQ | Planned |
| Total | 64.56K | $2.11M | ||